Latest ISN News

ISN News is brought to you by category and is updated regularly. Please select a news category from the list below, then select a news article to read.

beirutsabinaThe city's infrastructure, including supplies and services to the Renal Community, has been severely damaged, recounts Dr. Sabine Karam one month after Beirut suffered a massive explosion of such strength that it was felt 150 miles away in Cyprus, killing 190 persons and injuring some 6,500 others.

Dr. Karam, Head of the Division of Nephrology and Hypertension at Saint George Hospital University Medical Center, Beirut, Lebanon, and ISN Young Nephrologists Committee member gives a first-hand account of the disaster.

“Four hospitals in the vicinity of the blast were affected. Many patients were killed instantly or died while being transferred to remote hospitals to accommodate the overflow. Saint George Hospital University Medical Center (SGHUMC), the hospital where I practice, comprises 400 beds and a major dialysis unit with 92 chronic patients.

SGHUMC hosts one of only two pediatric chronic dialysis units in the country. Patients have been distributed throughout the region. Most of the equipment has been damaged. Only the emergency room and twenty hospital beds are currently available. It’s estimated that it will take at least a year for the rest of the structure to be rehabilitated if adequate funds can be secured.

Geitawi University Hospital comprises 270 beds and a dialysis center with 90 adult patients. Only the dialysis and burn centers are currently functional. It will be at least three months before the hospital is even partially available.

The Rosary Hospital and the Quarantina Governmental Hospital, which comprise 50 beds each, have been destroyed and are currently not functional. The Quarantina Hospital Distribution Center, serving as the primary drug supplier for all patients covered by the ministry of health, was also destroyed, compounding an already existing shortage of key medications at other governmental agencies due to Lebanon’s crippling financial crisis over the past ten months.”

Dr. Karam is a member of the Executive Committee of the Lebanese Society of Nephrology and Hypertension (LSNH).

The ISN Renal Disaster Preparedness Working Group (RDPWG) has been working alongside the Lebanese Society of Nephrology and Hypertension (LSNH) Disaster Task Force to support nephrologists and kidney patients in the area, says Dr. Adrian Liew, Director of the Kidney and Transplant Practice at Mount Elizabeth Novena Hospital in Singapore, ISN Executive Committee and RDPWG Chair.

The local Task Force has conducted assessments of renal patients, both adults and children, as well as compiling a list of the shortages at hemodialysis units and the clear deficiencies in the provision of inpatient renal replacement therapy.

Based on this survey results, other sources of information, as well as an assessment made by the field office of the World Health Organization on the availability of medications for renal patients (received on August 12, 2020) indicating a supply lasting one month at the central warehouse of the Ministry of Public Health, an urgent appeal and request for support and aid are being made, writes Prof. Ali K. Abu-Alfa, Head of the Division of Nephrology and Hypertension at the American University of Beirut-Medical Center, President, Lebanese Society

of Nephrology and Hypertension, and Deputy Chair of the ISN Middle-East Regional Board.

The ISN Renal Disaster Preparedness Working Group has been in contact with major institutions worldwide and coordinated assistance with organizations, such as the WHO, and major drug and equipment companies, to assist the disaster relief effort in Beirut.

Dr. Valerie Luyckx, Institute of Biomedical Ethics, University of Zurich, ISN Executive Committee and RDPWG member, connected Prof. Ali with the Deputy Medical Director at Médecins Sans Frontières in Beirut via the central office in Belgium to obtain storage space for medical supplies.

ISN Pioneer Awards honor the 'unsung heroes' of nephrology. They reward doctors on a regional level who have carried out extraordinary efforts to advance nephrology in a specific country or region.

This is the first time that the North America and the Caribbean region has been included in the Pioneer Awards and nominations are allowed ONLY from Grenada, Jamaica, Saint Lucia, and Saint Vincent and the Grenadines (these awards are restricted to non-high-income countries).

Eligible candidates:

  • Born in a non-high-income country and have worked in a non-high-income country for the great majority of their career
  • Medically qualified
  • Have not previously won an international award made by a major nephrology society
  • Are NOT active in current ISN leadership, i.e., Councillor, ExCom member, Committee member, or Regional Board member

As an ISN member, you can nominate a candidate by providing the following information via email to jdonner@theisn.org by September 8, 2020:

  • Nominator details: complete name, ISN membership number, and country
  • Nominee details: complete name (as listed in publications), country, and contact information (nominees do not need to be ISN members)
  • Support statement: explain why the nominee should receive the award (maximum 300 words)
  • Curriculum vitae of the nominee: 2-page maximum
  • Letter(s) of support: mandatory (no more than three)

If you have any questions about the Pioneer Awards, please contact the Awards Coordinator Jo-Ann Donner.

We look forward to receiving your nominations!

The ISN is currently calling for applications from health care centers to become recognized as ISN Interventional Nephrology Training Centers.

Such training centers work with the ISN to provide in-depth training in interventional nephrology to improve patient care in different regions of the world.

Read the detailed guidelines on how to apply.

Institutions from all countries (low, middle, or high-income) can

Apply Here

 

The deadline to apply is October 15.

Eligibility criteria to become an ISN Interventional Nephrology Training Center:

  • Have a minimum of 2 years experience in interventional nephrology.
  • Have performed at least 200 specific interventional nephrology procedures in the last 12 months.
  • Staff involved in training at these centers should be active members of the ISN community with
    full ISN Membership.

 The ISN will support trainees from low and middle-income countries with grants to contribute toward their travel, accommodation, and living costs during the training.

If you have any questions, please contact the ISN Programs team.

This initiative is supported by an unrestricted educational grant from


One World. One ISN.

The ISN supports clinical research projects that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease in emerging countries through the ISN Clinical Research Program (CRP).

Three CRP investigators recently completed their research projects:

Title of Grant:  

Acute Renal Failure in Children. Multicenter Prospective Cohort Study in Medium-Complexity Intensive Care Units from the Colombian Southeast.

Country

Colombia

From June 2016 to January 2020, a team of researchers identified children who developed compromised renal function during stays in intensive care in Popayan´s hospitals in the Cauca State in Colombia, where most people live in rural areas with a large indigenous population. These patients were matched with a control group from another medium complexity PICU from Cali, the capital of Valle del Cauca.

The study, led by Jaime M. Restrepo, was the first multi-center prospective cohort study conducted in Colombia in medium-complexity PICUs investigating renal involvement in children who enter pediatric intensive care. The hospitals involved are currently established within the ISN SRC-Trio Program.

The ethnicity, nutritional status, type of disease, and other important characteristics of the patients were recorded. Patients were followed up during hospitalization, and recovery or deterioration in renal function was monitored and supported with renal replacement therapy.

The results demonstrated:

  • A global 5.2% prevalence of acute kidney injury in pediatric intensive care units (2.7% severe cases; 11.8% mortality rate).
  • A majority of patients (77%) receiving subsidies from the Colombian government.
  • Over a third of patients (39%) with some form of malnutrition, making them more susceptible to developing infections, electrolyte disorders, and acute kidney injury.

Researchers from Cali- Popayan, from left to right: Ruben Lasso, Alejandra Agredo, Yessica Bravo, Jaime M Restrepo, Jessica Forero, María del Pilar Duque, Lina María Viafara, and Laura Torres.

Researchers from Cali- Popayan, from left to right: Ruben Lasso, Alejandra Agredo, Yessica Bravo, Jaime M Restrepo, Jessica Forero, María del Pilar Duque, Lina María Viafara, and Laura Torres.

 

The research provided a more accurate description of regional and national epidemiology to predict better AKI prognosis in Colombian pediatric patients and improve understanding of AKI in Latin America.

The project was carried out in line with the ISN 0by25 initiative to prevent all deaths due to AKI by 2025 and to conduct timely diagnosis and treatment of AKI to patients with reversible pathologies, especially in countries with low economic resources and limitations in access to health care.

The researchers stressed the importance of understanding local epidemiology to formulate and implement health policies to improve kidney care in the region and preserve kidney function in Colombian children.

Partial results were posted at the 9th International Conference on Pediatric Continuous Renal Replacement Therapy (PCRRT) in Orlando, Florida, in 2017. This research was awarded first place as an oral presentation at the VIII National Congress of Pediatric Residents supported by the Colombian Society of Pediatrics in November 2018.


Title of Grant:  

Renal health self-monitoring application

Country:

Brazil

The “Renal Health Project” study, based at the University of Fortaleza in Brazil, aimed to provide educational tools for patients with chronic kidney disease (CKD) and develop novel technologies to help CKD patients to self-monitor their treatment.

The project, supervised by Geraldo B. Silva Junior, was developed over two years and focused on education/prevention and adherence to kidney care treatments.

Social media strategies were implemented to share knowledge on kidney disease to the broadest audience possible, and the public’s general understanding of kidney disease was measured in both Brazil and Portugal.

Technological tools to monitor and improve adherence to patient treatment were developed to help people cope with kidney disease and complex procedures such as dialysis and transplants. These include an insole to automatically measure and register the patient’s weight, a "smart" pillbox to control medication intake, and smart bands to monitor vital signs.

An application, the Renal Health app, was developed to be used by transplant patients and those undergoing dialysis to help them monitor their treatment and to provide information on CKD. The app provides information to the general population on CKD prevention and calculates renal function by estimating glomerular filtration rate. It is currently available at Google Play and the Apple Store, in Portuguese, English, and Spanish.

Geraldo B. Silva Junior, discusses his findings with John Feehally and Brett Cullis at WCN’19, in Melbourne, Australia, during the ISN Clinical Research Awards special session.

Geraldo B. Silva Junior, discusses his findings with John Feehally and Brett Cullis at WCN’19, in Melbourne, Australia, during the ISN Clinical Research Awards special session.

Further research is planned to investigate the impact of the app on clinical outcomes. The hypothesis is that the app increases adherence to treatment, and therefore decreases the complications of dialysis and kidney transplant. Clinical studies in dialysis clinics and tertiary hospitals are already underway in Brazil.

The educational material developed by the team was also shared via a YouTube channel and an Instagram account. The Instagram profile has over 5,000 followers, and the renal health YouTube videos have been viewed more than 1,000 times.

The material in Portuguese received positive feedback from patients and health care professionals from around the world. Plans are underway to develop the content in English and Spanish.

According to the researchers, understanding the main gaps in the public’s knowledge of kidney disease in Brazil and Portugal provides the data necessary to improve screening campaigns in these countries.


Title of Grant:  

A prospective study of clinico-epidemiology, outcome, and catastrophic out-of-pocket expenditure associated with obstetrical-AKI

Country:

 India

This prospective study evaluated the causes and factors influencing the outcome of obstetrical-AKI, and the economic consequences on patients.

 Raja Ramachandran, evaluated patients with obstetrical-AKI, referred to the Postgraduate Institute of Medical Education and Research, Chandigarh, between August 2015 and August 2017.

 All the patients in the study were dialysis-dependent. AKI was most common during the third trimester (33%) and post-partum period (55%). The causes of AKI were found to be multifactorial:

  • 20% of patients had evidence of renal cortical necrosis.
  • 49% of patients either died or declared end-stage kidney disease.

The results demonstrated that AKI and consequential death are an under-reported cause of maternal mortality rate and that 93% of patient’s families experienced catastrophic out-of-pocket expenses.

These results were presented at the ISN World Congress of Nephrology 2017, Mexico City, Mexico, and ASN Kidney week 2018, San Diego, US.

Postpartum Renal Cortical Necrosis Is Associated With Atypical Hemolytic Uremic Syndrome in Developing Countries.” was published in Kidney International Reports.

Utility of serology in the diagnosis of pre-eclampsia and haemolytic uraemic syndrome in pregnancy-related acute kidney injury.” was published in Nephrology

 

The ISN advances its mission by providing resources like the ISN Clinical Research Program to the international nephrology community. Your continued support as an ISN member makes this possible.

In response to factors such as climate change, unsustainable kidney-treatment methods, and CKD epidemics due to toxins and extreme working conditions, the authors urge nephrologists to pay particular attention to the effects of global warming and its potential to cause acute and chronic kidney injury, severe dehydration, and electrolyte disturbances.

The authors propose a “planetary health” approach in which human health depends on the state of natural systems. This includes a focus on animal and environmental health to ensure the well-being of the whole planet. 

They suggest establishing a “biomimetic alliance for better health” with collaborative research among different disciplines to improve outcomes and lower the burden of lifestyle diseases, such as CKD, and create a more sustainable environment.

kireport

This longitudinal studyassessedfatigue and treatment status in patients with Atypical hemolytic uremic syndrome (aHUS) from the Global aHUS Registry.

The results confirm the detrimental effects of aHUS on patients’ daily lives, especially in terms of fatigue,butdemonstratessignificant improvement in symptoms following treatment with eculizumab.

The deadline to submit a potential candidate for 2021-23 President-Elect, or Regional Board Deputy Chairs/Councillors (all 10 regions) is August 31, 2020! 

Don’t miss your opportunity to put forward someone who can make a difference to regional and global nephrology in a leadership position at ISN. 

Suggest a candidate for President-Elect by emailing DTudor@theisn.org. Complete the online nomination formto suggest a candidate for Regional Board Deputy Chairs/Councillors.

READ FULL INSTRUCTIONS

Applications are open until October 31, 2020. Click here to apply

The year-long ISN-ANIO Clinical Nephropathology Certificaten Basic Program includes over 40 recorded online lectures and 12 live monthly webinars cover the main principles and practices of Nephropathology.

Discover more here.

"This is a wonderful course, did this last year. Highly recommended for fellows and early career nephrologists." Aakash Shingada, Director at Kidney Associate

"Great online program by ISN-ANIO. I did it in 2013. Inaugural session. Found it extremely useful." Prakash Gudsoorkar, Nephrology Specialist

Tuition fees are waived for trainees in MD, DNB, DM, or Ph.D. from low and lower-middle-income countries.

"No Brainer to do this!" Swapnil Hiremath, Nephrologist, Epidemiologist and # Neph JC cofounder

Complete and submit the online application form before October 31, 2020.

Any questions about the course or the application process?

Contact Dr. Youssef Farag: isnaniocnc@gmail.com

Apply today!

download 1

There are only a few days left for ISN Members to nominate a deserving individual for one of the following 2021 awards:

Discover more on ISN Awards and the nomination requirements HERE.

Award winners will be recognized at The ISN World Congress of Nephrology 2021, April 15-18, in Montreal, Canada, and virtually. ISN Pioneer Awards are presented during regional events throughout the year.

Support and honor your peers: Send your nominations and supporting materials to theISN Awards Coordinator before the deadline.

Are you interested in nominating someone but not yet an ISN member? Learn about our membership packages and join the ISN community today! 

The full DAPA-CKD trial results will be presented and reviewed at the ESC Congress 2020, Sunday, August 30, 17:00 – 17:30 CET.

Topic

Renal failure and Cardiovascular Disease

Chairpersons

Rory Collins (Oxford, UK); Frank Ruschitzka (Zurich, Switzerland)

Presentations:

  • DAPA-CKD – Dapagliflozin in Patients with CKD: Hiddo Heerspink (Groningen, Netherlands)
  • DAPA- CKD – Live Prime Discussion: Diederick E Grobbee (Utrecht, Netherlands)

Q&A Session

The online session is available free of charge, but pre-registration is required.

Look out for the upcoming ISN webinar on the implications of this new data on renal function and kidney care.

Would you like to support equal access to nephrology research? Become an ISN Member!

Read more

“The DAPA-CKD trial has shown dapagliflozin’s potential as a long-awaited new treatment option for patients with chronic kidney disease. The data will be transformative for these patients” - Prof. David Wheeler, University College London, and Prof. Hiddo Heerspink, University Medical Center Groningen, Co-chairs and Executive Committee of the Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial.

Faxiga met all primary and secondary endpoints in a groundbreaking Phase III DAPA-CKD trial for the treatment of patients with CKD.

Farxiga significantly reduced the worsening of renal function or risk of deaths in patients with CKD with and without type-2 diabetes.

High-level results from Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant and clinically meaningful effect on its primary endpoint of a composite decline in renal function or risk of death (defined as a composite endpoint of ≥50% sustained decline in estimated glomerular filtration rate (eGFR), onset of kidney failure, or cardiovascular, or renal death) in adult patients with chronic kidney disease (CKD).

The trial also met all its secondary endpoints in CKD patients with and without type-2 diabetes (T2D), making Farxiga the first medicine to significantly reduce the risk of death from any cause in this patient population.

Thursday, 20 August 2020 11:44

Global Trials

download.jpeg

The ISN-ACT Global Trials Focus team has collected and published a new list of randomized research from nephrologists around the world for August 2020.

Each trial is reviewed in context and the risk of bias in seven key areas is assessed.

Highlight:

Allopurinol does not slow the progression of chronic kidney disease in patients with type 1 diabetes.

See the latest trials here.

Would you like to support equal access to nephrology researchBecome an ISN Member

Kidney International will shortly publish the International Consensus Definitions of Clinical Trial Outcomes for Kidney Failure: 2020, developed from the 1st International Consensus Meeting on Defining Kidney Failure in Clinical Trials hosted by the ISN in Vancouver, BC, Canada, in early 2020.

This is the first attempt by the international nephrology community to identify reproducible, robust definitions of kidney failure outcomes and acceptable surrogates for clinical trials, to be used worldwide, in any resource setting. The final definitions, discussed in detail in the report, reflect the consensus for use in clinical trials.

These consensus definitions will improve consistency and understanding of results in clinical trials and the evidence base from which to treat patients with kidney diseases worldwide.

This initiative is part of ISN’s recognition of the importance of clinical research and the need to enhance clinical trials based on established endpoints with international relevance. Consider further supporting our work by becoming an ISN member.

The ISN invites nephrologists to register patients affected by COVID-19 on thenew global COVID registry (click on CORONATION tab).

The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection.

For more information, please visit ISN’s website section dedicated to COVID-19 resources or email add-tr.coronation@nhs.net.

It is part of ISN’s mission to provide resources like Coronation to the international nephrology community. Your continued support as an ISN member makes initiatives like these possible. Better Together – Renew or Join Today.

The ISN will contribute to a panel discussion, « A Global Perspective on Kidney Failure at the Innovations in Dialysis Expediting Advances Symposium (IDEAS) on August 31, 2020.

Representing the ISN on the panel are:

VivekanandJhaExecutive Director at The George Institute for Global Health, India, Chair of Global Kidney Health, Imperial College of London, President, International Society of Nephrology (ISN)

and 

Aminu Bello, Professor of Medicine, University of Alberta, co-chair, ISN Global Kidney Health Atlas (GKHA).

ISN’s participation will take place at 8am Pacific time/5pm CET.

Registration for the event is free for students. 

Stefaan Claus, RN

Nephrology Division, Ghent University Hospital, Ghent, Belgium

Member of the ISN Kidney Health Professionals Working Group

In October 2019, the International Society of Nephrology (ISN) organized a Continuing Nurse Education (CNE) program at the Kenyatta University Hospital Nairobi, Kenya.

One year earlier, in 2018, Professor Marie Richards, along with the local nurses in the renal unit and the heads of the Renal Nurse Education, made an evaluation of nursing activities in the dialysis department. Vascular access (VA), hygiene and infection control, and the general organization of a dialysis department were considered to be top priority and the most urgent for support and education.

Because the mission was directed at the nursing activities and responsibilities in the VA program, a team was put together and headed by nurses, supplemented by a vascular surgeon. Regarding the set-up and the contents of the program, a deliberate choice was made to guide nurses in the practical implementation of their theoretical knowledge of VA. The best way to do so is through bedside teaching.

In order to thoroughly discuss the various aspects of an AV fistula within the scope of VA, we opted for the clinical pathway that is recommended in medical literature:

  • Prior to the visit, the local nephrologists selected 35 patients from a group that had already started haemodialysis with a central venous catheter, or patients in the terminal phase of kidney failure.
  • Vessel mapping: using Doppler ultrasound, the vascular system of their arms was identified. Local doctors and nurses have been taught to perform that technique. To the retained patients (n=21), markings were applied on the selected arm as an aiming point for the surgeon.
  • AV fistula creation: during this week, Dr. Simon Fraser performed 26 surgical procedures on 21 patients. In five cases, a reintervention was required.
  • The nurses were being taught the clinical approach of a newly created fistula on a daily basis, for which the method of ‘look, feel, and listen’ was used.
  • Since patient education and training are of major importance, we took ample time to demonstrate which role and responsibility nurses could possibly have in that sub-domain.
  • The technical issues that the nurses dealt with were discussed every day. In order to reinforce the problem-solving ability of the nurses, the complications were analyzed bedside while looking for the best solution.
  • During the nursing training of the clinical assessment of fistulas, the Doppler ultrasound device was used to visualize, confirm, or correct their findings.

Nurses play a key role in patient care. In low-income countries (LIC) in particular, in which there is a large shortage of medically-schooled staff, their responsibility reaches further than the standard norm. Therefore, such bedside teaching helps to advance the existing theoretical knowledge into practice. Respecting and accepting the local situation are of crucial importance. By taking aboard the nurses in the Kidney Health Professionals Working Group (KHPWG), and by supporting CNEs, the ISN demonstrates the importance of education and training for this target audience in LIC.

During this mission, we organized training and education in what is only one part of the total care for a nephrology patient. My hope for future years is to be able to deal with other components as well, such as hygiene and infection control, prevention of renal insufficiency, and other aspects of care.

Many thanks to the Kenyan renal nurses of Kenyatta University Hospital, Marie, Thandi, Nancy, Simon, Valerie, Jo-Ann, Liselotte, and many others.

coronation eblast top banner

The ISN invites members to register patients affected by COVID on the new global COVID registry.

The ISN collaborated with the University of Cambridge to develop CORONATION, the Coronavirus multinational observational registry, a data entry portal accessible to nephrologists worldwide to collect anonymous data on individual people with kidney disease and the COVID-19 infection.

The initiative was led by Dr. Thomas Hiemstra (Nephrologist and Trials Methodologist, University of Cambridge; Chair, ISN-ACT Committee) and Dr. Fergus Caskey (Consultant Senior Lecturer, Bristol Medical School; Chair, SharE-RR; ISN Executive Committee Member) in response to the growing need to gather data to advocate for those with kidney disease, particularly in light of the significant impact the COVID-19 virus is having on those with non-communicable diseases.

For more information, please visit ISN’s website section dedicated to COVID-19 resources or email add-tr.coronation@nhs.net.

Monday, 03 August 2020 08:03

Nominate the next ISN President-Elect & Regional Board Deputy Chairs/Councillors (all 10 ISN regions)

Help shape the future of ISN: Nominate a potential candidate for the positions of 2021-23:

  • President-Elect, and
  • Regional Board Deputy Chairs/Councillors; 1 vacancy in each of the 10 ISN regions

As an ISN member, you can help advance kidney care worldwide by nominating candidates for ISN leadership positions. 

The ISN is committed to the principles of diversity and inclusion. We encourage nominations from eligible individuals across all regions, genders and ages!

Nominate a candidate for President-Elect


There is one (1) vacancy open for the position of 2021-23 ISN President-Elect.

  • Commitment: The ISN President-Elect deputises the President, who has the responsibility of leading the ISN in constant coordination with the Executive Committee. The President-Elect sits on the Executive Committee as voting member, and as a non-voting member of Council.

  • Term: The 2021-23 President-Elect’s term will start at the ISN World Congress of Nephrology 2021 (WCN’21), and continue until WCN’23, when the President-Elect will become President until WCN’25.

  • Eligibility: Every candidate for President-Elect must be a present or former member of the Executive Committee or Council, and an ISN Full member. Nominators too must be ISN members. Self-nominations are discouraged.

To nominate a potential candidate, please email Dominique Tudor by 31 August 2020 with:

  • the nominee’s name 
  • a short description of the nominee’s:
    • current/previous accomplishments as an ISN leader and volunteer, and
    • fit with the ISN mission, mind-set and spirit, based on concrete achievements

At this stage, no additional documents, CVs or other information are required. We will consider all nominees suggested, and request further documentation and information when necessary to assist our final decisions.

Nominate a candidate for Regional Board Deputy Chair/Councillor*

There is one (1) vacancy in each of the 10 ISN regions (listed below) for the position of 2021-23 ISN Regional Board Deputy Chair/Councillor.

 

* As Regional Board Chairs and Deputy Chairs cannot be from the same country, members from a country in which the current Deputy Chair resides (Cameroon, Czech Republic, Mexico, Lebanon, Kazakhstan, Canada, Japan, Australia, Nepal and Italy) will be ineligible to stand for the 2021 elections. Members from the countries listed above are encouraged to be nominated for the 2023 elections.

  • Commitment: Regional Boards are the regional representations of the ISN. They are the “eyes and ears” of the ISN across its whole range of activities, and a major means of integration with Affiliated Societies. The Regional Boards are led by a Chair, and Deputy Chair. Regional Board Chairs and Deputy Chairs also sit on the ISN Council.

  • Term: Regional Board Deputy Chairs’/Councillors’ terms start at WCN’21, and continue until WCN’23, when they will become Regional Board Chair/Councillor until WCN’25.

  • Eligibility: Nominees must be ISN Full members. Nominators too must be ISN members. Self-nominations are discouraged.

To nominate a potential candidate for a Regional Board Deputy Chair/Councillor position, please complete the online nomination form and send the nominee’s short CV in English (max 4. pages, academic CV may be referenced, or included as an appendix) to Dominique Tudor by Monday, 31 August 2020. The form will take approximately 10 minutes to complete, as you will be required to answer specific questions regarding the leadership skills and specific achievements of your nominee.

Please read for other important information

Those nominees shortlisted by the Nominating Committee (by end November 2020) will form the slate of candidates for the 2021-23 leadership elections (scheduled to open in February 2021).

Don’t forget that in order to nominate a candidate (or be nominated), your ISN membership must be current. Ensure you don’t miss out on this ISN member privilege.

Renew your ISN membership

Learn more about ISN’s leadership groups, positions and governance in the ISN Bylaws.

Please direct any questions about the vacancies or process to Dominique Tudor.

Thanks for your support in helping shape the future leadership of ISN!


Yours sincerely,


 Carol Pollock
   
 Chair, ISN Nominating Committee         

 

How does the ISN meet the challenge of presenting the latest complex ideas in easy-to-understand nuggets of information?

Discover the @ISNeducation Social Media Team and the ISN WCN Social Media Team.

Read more

ISN WCN Social Media Team

Over the past decade, Social Media (SoMe) platforms have become increasingly popular to disseminate information from medical conferences. Twitter has become a notably favored platform for nephrologists to share content.

To ensure comprehensive coverage of congress lectures and presentations across SoMe platforms, a SoMe Task Force (SMTF) was created by the International Society of Nephrology (ISN) at the World Congress of Nephrology (WCN) in Mexico in April 2017.

Now known as ISN WCN SoMe teams, these groups are created for all subsequent congress. The WCN’20 SoMe team has widely diffused scientific material from the WCN’20 congress program, which couldn’t take place due to COVID-19 restrictions.

@ISNeducation Team

After evaluating the work of the SoMe Task Force SMTF, the ISN decided to adopt its mission of providing comprehensive coverage of congress programs and activities as a core feature of its educational platform. 

The Social Media Task Force metamorphosed into the @ISNeducation Social Media Team and is now a component of the ISN Education Working Group.

Composed of both original SMTF members and new educators from around the world, @ISNeducation continues to present the latest complex ideas in an accessible way through a variety of social media platforms.

Discover the full story here.

The ISN is proud to provide educational resources to the international nephrology community. Become an ISN member and support our work.

Monday, 20 July 2020 08:41

Attend the ISN 2021 Frontiers Meeting

The International Society of Nephrology, in collaboration with the Mario Negri Institute for Pharmacological Research, will hold the ISN 2021 Frontiers Meeting on ‘Complement-related kidney diseases: classification, genetics, and treatment’  from July 1-3, in Bergamo, Italy.

This specialist meeting will focus on the two prototypical complement-mediated kidney diseases: atypical hemolytic uremic syndrome (aHUS), and C3 Glomerulopathies/Membranoproliferative Glomerulonephritis (C3G/MPGN), giving scientists engaged in rare diseases the opportunity to speed up research and drug development in the field.

All ISN members are cordially invited to register to experience cutting-edge science presented by a global panel of clinical and scientific experts.

ISN encourages those directly involved in this area of expertise to reach a greater audience by submitting an abstract for the event.

Through its Continuing Medical Education (CME) Program, the ISN was pleased to contribute to the 32nd Scientific Conference and General Meeting, held by the Nigerian Association of Nephrology in February 2020, in Ibadan, Nigeria.

The ISN supported two speakers to lecture at the event: Rasheed Balogun, Professor of Medicine at the University of Virginia Health System in the USA, and Prof. Hesham Safouh, Professor of Pediatric Nephrology at Cairo University in Egypt.

The three-day meeting was oriented toward a variety of healthcare practitioners involved in treating kidney diseases, including doctors, nurses, dietitians, pharmacists, and technicians. 6oo participants attended from around the country.

According to Aliyu Abdu, consultant nephrologist at Aminu Kano Teaching Hospital, Secretary-General of the Nigerian Association of Nephrology, and co-organizer of the event, the overall aim was to improve patient care in the region, notably through the practical sessions that took place at the conference.

The conference was an opportunity to present the ISN Pioneer Award for the Africa region to Prof. Oladipo Olujimi Akinkugbe, Emeritus Professor of Medicine, University of Ibadan, Nigeria, in recognition of his outstanding achievements in the field of nephrology.

Prof. Akinkugbe, who sadly passed away on June 15, 2020, was a widely published pioneer of nephrology in Africa responsible for training current leaders in the field in Nigeria. He instigated the establishment of two clinics at the UCH in Ibadan, one in hypertension and the other in renal disorders. Both clinics were firsts in Africa. The ISN offers its sincerest condolences to his family.

CME meetings, available to full ISN members, are designed to stimulate the interest of regional nephrology communities to expand their programs and networks and to inspire young professionals to become part of the ISN community.

Not yet a member? Need to renew your membership? Explore ISN membership packages here.

Monday, 20 July 2020 08:33

Global Trials

Every month the ISN-ACT Team lists interesting new randomized controlled trials from around the world.


Highlight:

  • Early ACE-inhibition is safe in pediatric Alport’s Syndrome and may be effective

See the latest trials here

Young ISN members from Bangladesh, Ghana, and Brazil reflect on their experiences on the frontline of the COVID-19 pandemic.

Read reflections from other young ISN members here.

Find resources relating to the COVID-19 infection here.

Reflections from Dhaka

Tania Mahbub, Consultant Nephrologist, ISN Fellow, United Hospital Limited, Dhaka, Bangladesh

Since it is a novel disease, the modus operandi of COVID-19 management has needed to change over time in Bangladesh in line with our country's needs and national guidelines of COVID-19 management.

Early in March 2020, when a handful of corona positive cases were detected, we focused mainly on prevention, educational programs for health workers regarding the management of the new disease, and updated training on personal protection.

For all patients coming to the hospital, including patients on dialysis, there is triage for preliminary screening. When patients present with suspected COVID-like symptoms, they are managed in separate zones. Direct OPD consultation is limited, and a telemedicine service has been developed to prevent disease spread from the OPD.

Special precaution was taken for the Dialysis Unit as a potential portal of infection. We’ve also educated the patients about preventive measures, symptoms of COVID-19, and advised them to seek help through telemedicine rather than coming directly to the Dialysis Unit. Throughout this period, we emphasize maintaining regular dialysis as volume overload may erroneously mimic the COVID infection. For emergency dialysis, we prefer Femoral Venous Catheterization instead of the Internal Jugular route. The use of complete PPE is mandatory during procedures.

Initially, COVID hospitals were designated in the country. When community transmission occurred on a large scale, the Health Authority decided to treat both COVID and non-COVID patients in all hospitals. We divided our hospital into COVID, non-COVID, and suspected COVID zones. Eventually, we started doing RT-PCR in our hospital. Currently, we are providing renal consultation, dialysis of COVID patients in the Critical Care Area, and have built a negative pressure isolation chamber for COVID positive dialysis patients.

In my experience, treating COVID and non-COVID patients in the same center is still challenging, especially when RT-PCR is not readily available, and waiting times to get test results are long. Further, a robust and integrated infection control strategy, surveillance, and logistical support are needed.

Sadly, many patients hide their actual history, thus posing a greater threat to physicians. As large-scale community transmission occurs, patients are now presenting with different symptoms and test COVID positive incidentally during screening. Sometimes highly suspected cases are found as COVID negative in an initial test, but subsequent test results prove positive. Therefore, I always emphasize wearing a proper N95 or equivalent mask/respirator to my fellow colleagues whenever they come into contact with any patient.

Bangladesh has unfortunately observed a high rate of physician deaths due to COVID-19 within a very short period. Therefore, priority measures need to be taken to find out the exact causes of their demise.

 

 

Patients are managed at the United Hospital, Dhaka, Bangladesh, during the COVID-19 pandemic

Reflections from Kumasi, Ghana

Greenshot 2020 07 23 11.00.30

Ever since we recorded our first two cases in Ghana on March 12, 2020, our COVID-19 cases have been rising.  According to the Ghana Health Services, as of June 28, we had 17,351 cases: 4,245 active cases, 12,994 recovered or discharged, and 112 deaths. We have tested 288,465 people so far, which is the third-highest rate in Africa after South Africa and Morocco.

There have been some government interventions to contain the COVID-19 virus. The first major intervention was the closure of the borders on March 22, 10 days after we recorded our first cases. Then a partial lockdown was declared in the epicenters from March 30 for three weeks to carry out aggressive contact tracing and minimize the spread of the virus. Although cases were still rising, the partial lockdown had to be lifted by the government due to social and economic hardships.

Restrictions on public and social gatherings were still in place, but these also eased as the president announced the lifting of the ban on religious activities with strict measures to govern services, such as a maximum duration of one-hour for up to 100 people and strict following of all safety protocols. The president encouraged social distancing and made the wearing of facemasks in public mandatory in Ghana, punishable by law, as additional restrictions were eased.

There is now a gradual effort to re-open schools. Final-year students in tertiary and secondary high schools resumed on June 15 to prepare their final examinations. On June 29, Junior High School final-year students resumed classes. School heads are expected to ensure all safety protocols.

My worry as a healthcare professional is the fact that there may be an escalation of cases, which might overwhelm our health institutions. Staff in most hospitals are decreasing as about 100 doctors have currently been infected with COVID-19. We have recorded two deaths from COVID-19, a Medical Director, and the renowned Nephrologist and Rector of the Ghana College of Physicians and Surgeons, Prof. Jacob Plange-Rhule. The Health Minister in Ghana has also tested positive for COVID-19.

With some people blatantly disregarding safety protocols after the easing of restrictions, and decreasing staff strength with inadequate provision of PPEs, I fear there will be more deaths from COVID-19 as cases increase. There is a possibility of an increase in the number of non-COVID-19-related deaths as a result of the shortage of staff due to self-isolation when exposed or overwhelmed with COVID-19 management, as written in an article I published, which was reported as a news item.

Unfortunately, this year is an election year for Ghana, and it’s worrying that political activities are going on with people flouting safety protocols of social distancing and wearing face masks. With the upcoming voters’ registration exercise starting on June 30 leading up to the elections in December 2020, we can only hope that these do not worsen the already increasing cases of COVID-19 in Ghana.

Reflections from Porto Velho, Brazil

Tatiara Bueno, Nephrologist, ISN Young Nephrologists Committee Member, SOS RIM clinic, Porto Velho, Rondonia, Brazil

Greenshot 2020 07 23 11.03.39

Three months ago, the coronavirus seemed to be a distant alert, but it quickly arrived in Brazil and had a different intensity among the macro-regions. Metropoles such as São Paulo and Rio de Janeiro were the first to experience the impact of the pandemic. Porto Velho, the capital of the State of Rondônia, in Western Amazonia, was not exempt from the pandemic route. It is a city with almost 550,000 inhabitants.

New ICUs were progressively opened, health teams were trained, schools were closed, and commerce was reduced. But all efforts failed to contain the increase in sick patients with severe evolution, especially in obese and male patients.

Within weeks, all ICU beds were occupied. Nephrology was essential; a large proportion of patients, especially those on mechanical ventilation, needed dialysis.

The challenges gradually appeared: doctors and staff fell ill, supplies were lacking or cost significantly more, and hours of overtime began.

In dialysis clinics, disease transmission was high among patients and staff, and even though these patients received all the necessary intensive support, death was almost inevitable. It felt like we were in quicksand.

In the midst of so much sadness and tiredness, something caught our attention: the strong teamwork. We were surprised by the feeling of solidarity and partnership. Those involved in the nephrology and intensive care sectors were fully focused on making the whole process feasible. That gave us the extra strength needed to continue day after day. 

Today, we are still in the middle of the hurricane, but we continue to be united, and we are sure that all this will pass soon. We will look back and be proud to have faced the COVID pandemic as nephrologists on the front line.

 Greenshot 2020 07 23 11.05.54Greenshot 2020 07 23 11.06.06

Managing kidney patients in Porto Velho, Brazil, during the COVID-19 pandemic

Launched in 2007, the Young Nephrologists Committee (YNC) engages younger ISN members to shape the future of ISN.

Find out more about YNC activities and initiatives here.

The YN Committee consists of members representing ISN’s ten global regions.

Would you like to advance kidney health worldwide? Help ISN to navigate the future of kidney care: Become an ISN members and join the YNC!

The ISN and Asian Pacific Society of Nephrology (APSN) have sustained a successful collaboration over the last decade, working together to advance kidney care in the Asia-Pacific region.

ISN is pleased to share with members that the APSN’s 18th Asian Pacific Congress of Nephrology (APCN) will take place from 2-4 October 2020 at the Hong Kong Convention and Exhibition Centre.

Because of ongoing uncertainties due to COVID-19, the local organizing committee will add a live online component to make this congress thefirst-everhybrid APCN.

 

The congress themeCombating CKD in the Asia Pacific: Local Strategies for a Global Problem, will embrace important topics on chronic kidney disease, acute kidney injury, glomerulonephritis, and advances in dialysis and transplantation.

To further enrich the program, abstract submissions forpapers related to COVID-19 have been accepted and experts from around the world in this emerging field have been invited to share their experiences.

Representing ISN participation, Germaine Wong will deliver ‘Clinical Care of COVID-19 Infection: Perspective of a Frontline Nephrologist’ in the Special Symposium: COVID-19 and Nephrology Practice on October 3. On October 4, ISN President-Elect Agnes Fogo will deliver the Chan Woon-Cheung Award Lecture, and ISN President Vivek Jha will present his talk, ‘Preventive Strategy for CKD based on Global Survey.’

ISN members may access the ISN-ACT (advancing clinical trials) Patient Engagement Working Group’s article, “International Perspectives on Patient Involvement in Clinical Trials in Nephrology,” published in KI on 9 July 2020.

The article highlights the important need to improve patient involvement in clinical trials to promote high-quality research in nephrology.

It describes also the current challenges to patient involvement in clinical trials, as well as the role of the ISN in promoting awareness of this need, and encouraging the development of tools and platforms to engage with patients.

Read the full article here.

Due to its timeliness, Seminars in Nephrology has made the current issue, Nephrology and Social Media, fully available to the public.

This issue focuses on the way medical professionals (#medtwitter) use Twitter and analyzes Twitter's role as a new tool for learning, teaching, networking, professional development, mentorship, sponsorship, and advocacy within medicine.

The edition examines the principles of adult learning theory to support the effectiveness of the use of Twitter as an educational tool and shares best practice tips.

ISN members can subscribe to Seminars in Nephrology at a special rate; visit the Seminars in Nephrology page for more information.

Stay connected in uncertain times.

Hosted by the Canadian Society of Nephrology (CSN) and la Société Québécoise de Néphrologie (SQN), WCN’21 remains scheduled from April 15-18, 2021 in Montreal, Canada

The far-reaching consequences of the COVID-19 pandemic will continue to impact the way we share knowledge. The ISN is adjusting to this reality and is closely monitoring developments and following advice from national and international authorities to implement all measures necessary.

WCN’21 will deliver the high-quality educational experience and opportunity for scientific discovery, networking, and professional development that you have come to expect, in a format that works for you!

Stay tuned for the latest developments at www.theisn.org/wcn21 or via ISN social media platforms.

Submit an abstract for WCN’21 here.

In Episode 4 of the ISN Global Kidney Care Podcast (GKCP) series, the hosts converse with Hernando Trujillo and Angel Sevillano (Hospital Universitario 12 de Octubre in Madrid, Spain) authors of the Kidney International Reports article, “SARS-CoV-2 Infection in Hospitalized Patients With Kidney Disease.”

The discussion considers the findings in the article and explores the professional and personal struggles both nephrologists faced at the height of Spain’s COVID-19 pandemic.

GKCP is hosted by Roberto Pecoits-Filho, Senior Research Scientist at Arbor Research Collaborative for Health in Michigan, USA; Deputy Chair, ISN Education Working Group, and Smeeta Sinha, Chair of North West England Renal Network.

Ethical challenges in nephrology: a call for action by the ASN/ERA-EDTA/ISN Joint Working Group on Ethical Issues in Nephrology, has been published in Nature Reviews Nephrology.

The paper identifies ten broad areas of ethical concern as priority challenges that require collaborative action to highlight the need for ethical analysis of issues within kidney care and to develop tools and training to support nephrologists to practice ethically and contribute to ethical policy-making.

Read the full paper here.

All three of the ISN journal websites (https://www.kidney-international.org/, https://www.kireports.org/, and https://www.kisupplements.org/) have been converted from traditional article pages to a new responsive design format to better respond to the needs of readers and the devices they're using.

Friday, 03 July 2020 15:10

Milestones in Nephrology

Founding papers on current nephrology: from acute kidney injury to diabetic kidney disease

As part of ISN’s 60th-anniversary, Kidney International’s “Milestones in Nephrology” series highlights five significant contributions to acute kidney injury, diabetic kidney disease, and cell biology:

Glomerular hemodynamics in experimental diabetes mellitus (Hostetter TH, Troy JL, Brenner BM, 1981)

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial (The Diabetes Control and Complications Trial (DCCT) Research Group, 1995)

Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury (Han WK, Bailly V, Abichandani R, et al. 2002)

HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney (Ryan MJ, Johnson G, Kirk J, et al. 1994)

Identification of the renal erythropoietin-producing cells using transgenic mice (Maxwell PH, Osmond MK, Pugh CW, et al. 1993)

The COVID-19 pandemic is likely to disproportionately impact people living with kidney disease. It is, therefore, more important than ever to monitor the care being delivered to patients with kidney diseases and to use data to advocate for those at risk of adverse outcomes.

Recognizing this, the ISN has launched several data collection initiatives over the past few months. In collaboration with the DOPPS Program team at the Arbor Research Collaborative for Health, Michigan, USA, the ISN will conduct a ‘practice patterns’ survey of the impact of COVID-19 on hemodialysis and peritoneal dialysis programs around the world.

The survey will be offered worldwide via the ten ISN Regional Boards.

Countries currently active within the DOPPS program will not need to repeat the survey; their data will be combined with the other countries to produce a global picture.

To discover more about ISN’s collaboration with DOPPS, please visit our website.

The International Society of Nephrology urges all investigators and industry partners to include people with kidney diseases in research activities related to COVID-19.

The ISN-ACT (Advancing Clinical Trials) Committee has released a statement on the urgent need to include patients with kidney diseases in clinical trials related to COVID-19.

Despite preliminary studies demonstrating the increased risk for people with kidney diseases to develop severe COVID-19 symptoms or to die from COVID-19, kidney patients are frequently excluded from COVID-19-related clinical trials. Effective therapies are needed to prevent and treat COVID-19 in all patients, including those with kidney diseases, and to reduce the current burden to healthcare systems.

Read the full statement here

ISN Educational Ambassador, Nitin Kolhe, consultant nephrologist at the University of Derby and Burton (UHDB) NHS Foundation Trust in the United Kingdom, spent a week at Mpilo Central Hospital in Bulawayo, Zimbabwe as part of the ISN Educational Ambassadors Program (EAP) in March 2020, before COVID-19 restrictions were in place.

UHDB nurses Sister Carol Rhodes and Sister Claire McGuire accompanied Dr. Kolhe on the visit. The aim was to train local staff in kidney biopsies and peritoneal dialysis services, and how to reduce infections.

According to Dr. Kolhe, patients in Bulawayo tend to present late with advanced kidney disease, and recognition of acute kidney injury and chronic kidney disease in primary care is poor. Patients are unable to receive peritoneal dialysis at Mpilo Hospital, and hemodialysis can be interrupted by frequent electricity loss and machine breakdowns. Patients may have to travel up to 300 kilometers for treatment and buy any equipment for dialysis themselves. 90% of patients are dialyzed on vascular catheters because no vascular surgeon can perform AV Fistula. Kidney biopsies have not been performed in public hospitals in Zimbabwe for more than two decades; they are only done in the private sector in Bulawayo because there is no formal renal biopsy program in government hospitals.

The team from UHDB provided teaching on recognizing acute kidney injury and investigating and managing chronic kidney disease in the community. Dr. Kolhe gave training on all aspects of performing kidney biopsy and setting up a peritoneal dialysis program.

Doctors and nurses received hands-on experience of inserting peritoneal dialysis catheters and scanning kidneys in three patients and one volunteer. Dr. Kajawo, a clinical nephrologist at Mpilo Hospital, performed two kidney biopsies under the guidance of Dr. Kolhe using real-time ultrasound guidance. A diagnosis based on a review of histology slides was made in a public hospital in Zimbabwe for the first time in more than 20 years.

Staff at Mpilo Hospital learned how to deal with potential complications following kidney biopsy in different case scenarios. The aseptic no-touch technique (ANTT) was demonstrated, as well as hand-washing techniques and the correct use of gloves.

The favorable exposure surrounding the visit helped raise awareness of the challenges in local kidney care. The Minister of State for Bulawayo Metropolitan Province, Honorable Judith Ncube, pledged to support kidney health initiatives, promising to help Dr. Kajawo in procuring peritoneal dialysis fluids and kidney biopsy needles.

Dr. Kolhe was impressed with the dedication and goodwill of local doctors and nurses despite the sub-optimal working conditions. He has invited Dr. Kajawo, and his colleague Sister Pat, for a week of training at the Royal Derby Hospital. He comments: “For the Mpilo kidney unit, continuity is important. ISN is doing a wonderful job of educating the developing world. EAP equips local doctors with knowledge which they cannot afford to get.”

ISN Awards acknowledge exceptional contributions to nephrology and are a chance to celebrate individuals for their role in enhancing the field of nephrology and ISN’s mission to advance kidney health worldwide.

The deadline to submit nominations for the ISN 2021 Awards is August 27, 2020.

Discover more on ISN Awards and submit nominations HERE.

Read about the 2019 awardees here.

Reena Rachel George, RN, MSN

Professor, College of Nursing, and Nurse Manager, Dialysis Unit and Renal Transplant Unit, Christian Medical College, Vellore, India. Member of the ISN Kidney Health Professionals Working Group

The incidence and prevalence of chronic kidney disease is increasing nationally and globally owing to the growing percentage of population living with diabetes and hypertension. 20-30% of patients with kidney failure in India are not initiated in any form of kidney replacement therapy (KRT) due to inaccessibility to healthcare facilities or financial constraints. Popularity for peritoneal dialysis (PD) is gaining momentum in India since its conception in the year 1991. The fact that PD therapy does not require vascular access or a healthcare facility and that it can be learned and performed by patients or their family members in their own homes makes it a viable and attractive option of KRT for many. The scope of PD nurses is immense as they can demonstrate autonomy in their roles as educators, counsellors, facilitators, patient advocates, and researchers. Nurses adequately trained in PD will be able to efficiently run PD programs in their setting in coordination with the nephrology team, incorporating evidence-based scientific knowledge.

The College of Nursing and Department of Nephrology at the Christian Medical College in Vellore, India, designed a short course on peritoneal dialysis nursing to give registered nurses (GNM and BSC) the specialized knowledge, skills, and competence to provide PD to patients with kidney failure. The course would also equip nurses to educate, train, and counsel patients and caregivers on various aspects of PD therapy. The 4-week course consists of 27 hours of structured theory, 153 hours of clinical practice, and would be offered multiple times throughout 2020.

Professor Reena George, course Coordinator, states: “Christian Medical College in Vellore, South India is a 2900-bed tertiary care teaching hospital with a well-established Dialysis unit. We have 70-80 patients initiated on Peritoneal Dialysis each year, having about 180 patients for training and follow up. The facility adheres to the international standards and protocols of care and has a nursing and medical faculty who are adept at teaching/training in PD. Our department provides an excellent opportunity for kidney health professionals from elsewhere to come and learn and hence this endeavour. A similar training program in hemodialysis training is also being planned.”

How do patients in the Nephrology Unit in Assiut, Egypt, feel about the impact dialysis has had on their lives?

How does a low-resource community in Kenya help a member who needs a kidney transplant?

How does a mother in Malaysia cope when her daughter develops kidney failure?

Discover these and other accounts in the shortlisted ISN Community Films and vote for an overall winner here.

The winner will be announced on June 26.

In 2019, ISN welcomed 40 Fellows from around the world. ISN congratulates all graduated fellows and presents here a sample of experiences to highlight the capacity building and impact to kidney care made possible through the ISN Fellowship Program.

Xu Chen, from the Affiliated Hospital of Nantong University, Nantong, China, trained for 12 months in Glomerular Disease, AKI, and CKD under mentorship from Jonathan Barratt at the John Walls Renal Unit in Leicester General Hospital in the UK with support from the ISN Fellowship Program and Kidney Research UK.

Xu Chen developed basic science and clinical research skills in the study of glomerular disease. She developed an in-depth knowledge of laboratory and clinical research in IgA nephropathy. In particular, she focused on comparing Caucasian and Chinese IgAN populations concerning biomarkers of disease.

According to Xu Chen, both the incidence and prevalence of kidney disease in her home region are on the increase, but effective therapeutic strategies for CKD are limited. Patients rely on dialysis and renal transplantation, which cannot prevent all the complications of CKD. An improved understanding of the nature of CKD progression is needed, as well as effective therapeutic methods.

Xu Chen received training in a range of laboratory and analytical methods in anticipation of leading a laboratory-based research program on her return to China. Xu comments: “I believe Nantong will benefit greatly by the increased exposure to research and clinical training offered by Leicester.”

The Affiliated Hospital of Nantong University collaborates on several initiatives with Leicester General Hospital through the ISN SRC Program.


 

Judith Aujo from the Mulago National Referral Hospital in Kampala, Uganda, spent two years training at the Red Cross War Memorial Children’s Hospital in Cape Town, South Africa, under mentorship from Professor Mignon McCulloch and Dr. Peter Nourse, supported by ISN and the Salmasi Family.

Judith’s training focused on general pediatric nephrology, dialysis, and transplant. Her training highlighted the need to produce data to lobby governments for improved pediatric renal services and patient care.

According to Judith, kidney care in Uganda is generally poor. The prevalence of CKD is over 20%. There are around 11 nephrologists in Uganda for an estimated population of 39 million and no trained pediatric renal nurses. Most of the doctors and services are in the capital city; so, Judith’s home institution in Mulago receives referrals from across the country even though they have no designated area for pediatric dialysis, but access the service from the adult dialysis unit.

Judith plans to train others in her home institution, commenting: “It was a great opportunity for me to have this training. I have learned a lot, appreciated the many gaps in our healthcare systems back home, but also realize that things can be improved. I look forward to having other colleagues get this training opportunity so as to build bigger teams.”

Judith is currently at the forefront of running the pediatric renal services in Mulago and is working to establish a functional (acute) PD program. She will be involved in transplant activities when Mulago Hospital starts this service.

Professor McCullogh adds: “This is such an excellent program for training fellows in Africa. Judith benefitted from two years and really secured her knowledge and became confident.”

The Mulago National Referral Hospital has an SRC link with the Baylor College of Medicine in the Texas Children’s Hospital in the US.


 

Maisarah Jalalonmuhali, from the University of Malaya in Kula Lumpur, Malaysia, trained under mentorship from Patrick Coates in kidney transplantation at the Royal Adelaide Hospital in Adelaide, Australia, with support from the ISN and CREED.

Maisarah was involved in several clinical research projects as part of her training objectives. Her paper: Serum Free Light Chain as Surrogate Marker For Renal Activity In Lupus Nephritis won third place in the Fellowship Program Awards at WCN 2019.

Maisarah was able to conduct hands-on laboratory immunology tests and became confident in managing pre and post-transplant care, immunology interpretation, and long-term complications following transplantation.

According to Maisarah Jalalonmuhali, there is good dialysis support in Malaysia, but kidney transplantation knowledge needs developing. She says her training will help improve transplant care and believes the number of transplants in Malaysia will increase. She comments: “It was a great fellowship program with many opportunities and exposure regarding kidney transplants.”


 

Nirajan Mainali, from the Nobel Medical College Teaching Hospital in Biratnagar, Nepal, trained in renal and transplantation pathology under mentorship from Dr. Kim Solez from the University of Alberta in Edmonton, Canada.

Nirajan gained extensive experience in native kidney and transplant kidney pathology as well as in composing kidney biopsy reports. According to Dr. Solez, Nirajan “became an excellent renal pathologist” during his time at the University.

Nirajan submitted two case studies from his training as abstracts for WCN20 that were accepted for presentation as posters.

According to Nirajan, renal pathology services in Nepal are limited. He aims to establish a renal lab there and believes his training will help make a noticeable difference in the region. He comments: “It was a great program.”


 

Francisco Vargas, from Hospital Doctor Arnulfo Arias Madrid in Panama City, Panama, trained in clinical nephrology and renal transplantation and dialysis under mentorship from Dr. Manuel Praga at the Hospital Universitario 12 de Octubre, in Madrid, Spain, with support from the ISN and SLANH.

As part of his training, Francisco spent two months in transplant consultation following up on post-operative kidney transplant patients and assisting in the treatment of patients with other organ transplants referred to the nephrology department. Francisco was impressed by the collaboration between the nephropathology group and nephrologists as well as with other surgical teams to obtain the best results for patients. He comments: “From the moment I arrived in Madrid, the treatment offered by Dr. Prague and his team of nephrologists and residents was excellent. I was quickly integrated into daily work and teaching. I will be eternally grateful to the Nephrology service of the 12 de Octubre Hospital.”

According to Francisco, there is an epidemic of patients with CKD in Panama and an increasing number of patients who have difficulty accessing the dialysis they need. Panama City requires three or four additional hemodialysis rooms, and the number of transplants has fallen dramatically over the past five years.

Francisco plans to advocate for the development of nephropathology services in Panama and the need to update treatment and care protocols in clinical nephrology and renal transplantation. He wants to encourage new professionals to specialize in nephrology and is currently teaching Nurses and Postgraduates in his home institution.

Young ISN members continue to work on the frontline of the COVID-19 pandemic. Rhys Evans, a member of the ISN Young Nephrologists Committee, asked young ISN members from India, Ecuador, and Nigeria, to reflect on their experiences.

Read reflections from other young ISN members here.

Find resources relating to the COVID-19 infection here.

Reflections from Chandigarh, India

Joyita Bharati, Assistant Professor, Chandigarh, India

Health care systems across the world are bearing the brunt of COVID-19. Cases continue to increase in India despite the country being in an extended lockdown of all non-essential services since March 24, 2020.

The fear of transmission of COVID-19 led to the closure of many private dialysis units across the country and, hence, many patients were under-dialyzed or not dialyzed at all. We get referrals from various states and the number of patients who present with symptoms due to inadequate dialysis has increased remarkably. Most of them are patients on chronic dialysis and present with increasing shortness of breath, with or without fever. Once tested for COVID-19, these patients are shifted to a designated COVID-19 wing of the hospital. While waiting for the COVID-19 report, which takes a few hours, most of them need urgent dialysis.

There is a significant overlap between pulmonary edema-related bilateral lung shadows and COVID-19 pneumonia-related bilateral lung shadows. Most often, patients with fluid overload do not manifest characteristic lung shadows with peripheral sparing, and lung ultrasound B-lines used to monitor patients, along with bilateral involvement, are present in both conditions. Moreover, septal thickening and pleural effusion are also seen in severe COVID-19 pneumonia. Unless the patient has multi-organ dysfunction with hematological involvement, excluding COVID-19 pneumonia in a chronic dialysis patient, especially if previously inadequately dialyzed, is difficult.

In the absence of universal and standard testing policies, appropriate allocation and adherence of personal protection equipment are likely to help prevent transmission of COVID-19 in dialysis units and allay fear amongst private centers catering to large patient populations.

Reflections from Cuenca, Ecuador

Diego Coronel Aguilar, Nephrologist, Cuenca, Ecuador

I am a Nephrologist in Cuenca, Ecuador. Cuenca is the third biggest city in Ecuador. Currently, we have 43120 cases in Ecuador, and about 3621 deaths with PCR tests confirmed mostly in Guayaquil. The situation is getting worse every day because the number of cases is increasing around the country. The number of cases in Cuenca is 884.

We have two main hospitals in the city. I work in one of them, Hospital Jose Carrasco Arteaga (Figure 1), which is a public hospital. Unfortunately, at the moment, the situation does not seem under control because the hospital has a lot of COVID-19 patients and the number of cases is changing every week. The number of patients in ICU is variable: the unit has a total of 12 beds, but at this time, no beds are available.

Nephrologists here are currently part of a back-up team in case the situation becomes critical. We received training courses on the clinical management of COVID-19 and the orotracheal technique. At the same time, we are doing night shifts to support the main COVID-19 team in general patient care.

Within the nephrology department, we have not had many cases yet: one kidney transplant patient, one chronic dialysis patient, and two with acute kidney injury, out of approximately 25 patients in total. I think, in the beginning, we had the situation under control because the population was strictly following the government recommendations to quarantine and practice social distancing and good hygiene. But these measures are being progressively lifted.

I also work in a dialysis unit where we carry out triage and isolate patients with respiratory symptoms until the test for COVID-19 can be done. If the test is positive, the patient has to be isolated in the unit or a specific area within the unit. We’ll see how the situation goes, but to be honest, I am not very optimistic!

Hospital Jose Carrasco Arteaga, Cuenca, Ecuador

Reflections from Ife, Nigeria

Oguntade Hameed, Senior Registrar, Nephrology Unit, Obafemi Amolowo University Teaching Hospital, Ife, Nigeria

The COVID-19 pandemic is, without a doubt, the most challenging health issue at the moment. This disease has disproportionately affected developed countries with more robust health systems.

Nigeria is a country with an estimated population of around 180 million. The country recorded its first case on February 27, 2020, and has since confirmed 12, 486 cases with 354 deaths.

I work in the Renal Unit at Obafemi Awolowo University Teaching Hospital as a Senior Nephrology Registrar. The dialysis unit is the biggest in the state, carrying out around 90 dialysis sessions per month.

Since the outbreak of COVID-19, the unit has developed a protocol with timely updates. Firstly, the unit organized a sensitization and awareness lecture for its members: doctors, nurses, health attendants, and biomedical engineers working in the unit. After that, a protocol was developed that make the use of face masks mandatory for staff and patients in and around the dialysis room. Regular hand washing is emphasized, and patients and visitors must wash their hands before gaining access to the dialysis room and the renal wards. The unit procured PPE that includes disposable surgical gowns, goggles, and face shields to be used by all staff working in the dialysis room.

The unit has tested five suspected cases based on symptomatology and travel history. All five samples returned negative. The unit continues to promote behavior to prevent COVID-19 while making PPEs available to all health workers and, where any case is suspected, prompt testing is carried out.

 

 

ISN BetterTogether COVIDAs COVID-19 continues to have a global impact, the ISN reached out to its members around the world to hear about the crisis in their own words. Below are some first-hand accounts.

What has your experience been so far? ISN members are encouraged to tell us on Twitter or Facebook using #ThisIsISN and have your testimonial added here.

“During the quarantine period, my life has been frantic: taking care of children and homeschooling, increased workload, and living closely with the suffering of patients with COVID and their families; also participating in organizing the conversion of our Brazilian Congress of Nephrology into virtual form ... quarantine for health professionals without time to look back...let's keep going ...” D. Machado (Brazil)

“While people were locked down at home, my hospital became busier. I had to balance working from home in virtual clinics at night with seeing patients in the hospital in the morning. I enjoyed my rest time with my wife and kids at home.” Ahmed Akl (Egypt)

“During this time, I realized that nature is more powerful than us and can easily get rid of humankind if it wants to.” S. Bek (Turkey)

“In this pandemic time, I work mostly from home completing my last month in nephrology training, spiritedly finalizing my Advanced CNC from ISN-ANIO, and excitedly retraining my rusty cooking skills.” R. Duarsa (Indonesia)

“Lockdown made me rediscover a) my neurosurgeon husband's cooking and b) music and movies in my mother tongue.” U. Anandh (India)

“In these chaotic days, when you are overwhelmed by the context and the day-to-day exhausting work... there is nothing like getting home and feeling the love of your family, they heal everything.” A. Pastor (Peru)

“I was an intern when all hell broke loose with AIDS in 1982. Now, I’m a senior nephrologist on a COVID-19 service. Many lessons to be learned and relearned… don’t fear the virus, respect it. Move forward in a mission of service with humility, grace, and dignity for all.” K. Tuttle (USA)

Due to the critical COVID-19 situation, we were obliged to reshape our planned activities changing from face-to-face interactions to virtual ones. After brainstorming ideas between the teams, we decided to organize a set of webinars with useful information and exchange of personal experiences facing colleagues in our respective hospitals. Given the situation where Spain has passed the crisis, but the Philippines are in the middle of it, we believe that these webinars will give ideas and support to our Filipino colleagues in dealing with this situation.” E. Kondi (Spain)

Among my lasting memories of this strange time will be carefully passing food to my wife in the bedroom through a barely opened door while she was isolated pending swab results. She has been ‘query COVID’ three times now, but fortunately, she has never tested positive. The dog had a great time running between us (via the cat flap) as we competed for the affection of this furry fomite.” Brendan Smyth (Australia)

These days, finding the right balance between hospital assistance and home studies has become a hard task. I joined my children’s violin lessons to better cope with the uncertainty and anxiety. Additionally, I have strengthened ties with the ISN Education group to keep focused on a scientific view of the pandemic.” Augusto Cesar S. Santos Jr. (Brazil)

During this pandemic, I have realized that there is always a way to improve our health system. COVID-19 does not discriminate and does not look at race, sex, age, skin color, socioeconomic status, or educational level.  It continues to teach us that we are just humans and that in order to achieve change, it is necessary to teamwork.” Angie Aguilar Gonzales Lizet (Guatemala)

I am a nephrologist and involved in the care of COVID-19 cases too. Patients are developing oliguric AKI and proteinuria. Dialysis is affected as we are using alternate machines to keep a safe distance. I think the biggest challenge is that we don’t have treatment. My personal opinion is that we should do an autopsy on every mortality, which will help understand the disease’s pathophysiology in a better way.” Sourabh Sharma (India)

Biggest fear is the increased risk of transmitting the infection to loved ones.” Priti Meena (India)

I review most patients admitted to the isolation ward with my medical officers. The majority are asymptomatic, a few have mild symptoms, and I’ve had two with pneumonia, none with renal involvement. I am the only nephrologist working in the center. Three of my patients are diabetic and faced with the challenge of detailed investigations due to limited resources, for example, renal ultrasonography, urinary albumin creatinine ratio, shortage of manpower, including lab staff.” Osariemen Osunbor (Nigeria)

I am working as Head of Nephrology Unit in Makassed Hospital. Our hospital has a capacity of 300 beds as well as its tertiary hospital in Palestine. We prepared an independent department for COVID-19, but up till now, we do not have COVID-19 inpatients in our hospital. We prepared and trained the team well to deal with them.” Mohammad Bourini (Palestine)

Dialysis patients, as well as Nephrologists, are being affected in the dialysis unit.” Dr. Abu Zafor Md. Salahuddin (Bangladesh)

The COVID-19 pandemic compelled me to change my daily routine. I have started learning new skills from the internet. Reading non-COVID-related articles as much as possible!” Shubbarthi Kar (Bangladesh)

Being a nurse manager in a dialysis unit, having to plan dialysis sessions separately for positive, suspected, and regular patients, and planning optimal staffing, was challenging. This was also a period when, as teachers, we had to explore and experiment with various online modes of teaching for students. However, this season also allowed experiments in cooking, gardening, and quality time with family members!” R. George (India)

As a solo nephrologist in my hospital, which turned out to be a COVID-19 hospital, my working hours increased from 8 hours to 10-12 hours daily, 24/7 on-call, working every day including weekends, for more than two months. Even though I'm physically and mentally exhausted, once I'm back home, I have the full support of my family, and I thank GOD we're all well and safe.” B. Bernieh Al Ain (UAE)

"During this period, though we had a hard time at the hospital taking care of COVID-19 patients, I had a lesser number of regular patients to visit, less travel for work, no social meetings to take part in, and more time to spend with my family, cook, read, and rest. It felt like being on a dangerous vacation!" S. Ossareh (Iran)

Having teleconferences with my colleagues working from home has provided a ‘window’ into their personal lives, and I have enjoyed seeing their home surroundings and occasionally their children and pets.” J. Donner (Canada)

The ISN is proud to provide a platform for the international community to share resources, guidance and experiences in times of crisis. 

Become an ISN member today and support our work.

#Bettertogether #ISNFamily

ISN is pleased to invite you to the KDIGO Diabetes in CKD Guideline Webinar: Looking at the Latest Evidence and Beyond, to be held on Monday, June 22, 2020 at 06:00 PM CEST.

Join the webinar to learn more about the new KDIGO Guideline on Diabetes Management in CKD, focusing on topics such as glycemic monitoring and targets, lifestyle and anti-hyperglycemic interventions, and approaches to self-management and optimal models of care.

  Date: June 22, 2020
  Time: 6:00 PM CEST
Register Now

To learn more, watch the video introduction to the new KDIGO Diabetes Guideline below.

Speakers

Chairperson

Ian de Boer

Ian de Boer, MD, MS
(Work Group Co-Chair)

Ian H. de Boer is Professor of Medicine and adjunct professor of epidemiology at the University of Washington in Seattle, WA, USA. Dr. de Boer received his medical degree from Oregon Health Sciences University. He trained in internal medicine at the University of California, San Francisco, and in nephrology at the University of Washington, where he also earned a master’s degree in epidemiology. Dr. de Boer practices nephrology at the Puget Sound Veterans Affairs Healthcare System and is an associate director of the Kidney Research Institute at the University of Washington.

Dr. de Boer’s research focuses on the prevention, diagnosis, and treatment of diabetic kidney disease (DKD) and its complications. His epidemiology work has helped define the clinical course of kidney disease in types 1 and 2 diabetes, including prevalence, incidence, risk factors, outcomes, relationships with cardiovascular disease, and the impact of diabetes treatments; his additional work also employs patient-oriented physiology research and clinical trials. Dr. de Boer has published more than 300 manuscripts in the field and was elected to the American Society for Clinical Investigation for these research contributions. He served on the American Diabetes Association Professional Practice Committee from 2016-2019, chairing the complications subgroup which oversaw development of the Standards of Medical Care in Diabetes, and is currently deputy editor of the Clinical Journal of the American Society of Nephrology.

Living with Diabetes and CKD

Tami Sadusky

Tami Sadusky, MBA
(Work Group Member)

Tami Sadusky received a pancreas and kidney transplant in 1993 and a second kidney transplant in 2011. She was diagnosed with type 1 diabetes at the age of 13 and, within 20 years, had developed complications from the disease, including kidney failure. The transplants brought her a new life.

Tami received her BS and MBA degrees prior to moving to Washington, where she worked at the University of Washington (UW) for 22 years as executive director of Research Finance and Operations. She is now an active volunteer in the areas of organ donation and transplantation and has been invited to speak about her patient experience both pre- and post-transplant. She is on the board of directors for Transplant House, a non-profit organization that provides housing for transplant patients. She is an active member of the UW Transplant Advisory Council, the UW Kidney Education and Support Group, the UW Team Transplant Strategic Planning and Finance Committee, the Kidney Research Institute Advisory Council, and works closely with the Northwest Kidney Centers. Three years ago, Tami established a UW gift fund, the Sadusky Diabetes Kidney Research Fund, which supports diabetes and kidney research.

Tami has been involved with KDIGO for the past two years developing the KDIGO Clinical Practice Guideline for Management of Diabetes and Chronic Kidney Disease.

Management of Diabetes in CKD

Peter Rossing

Peter Rossing, MD, DMSc
(Work Group Co-Chair)

Peter Rossing is a clinician researcher devoted to complications in diabetes with a focus on renal and cardiovascular complications. He obtained a specialist degree in internal medicine and endocrinology in 2004. Since 2007, he has been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro and macrovascular complications of diabetes.

As a professor in diabetic angiopathy at the University of Copenhagen since 2012, Dr. Rossing has conducted epidemiological studies investigating key features of the pathophysiology of the diabetic kidney at different stages. He has identified several markers for the development of diabetic nephropathy, making it possible to predict individual risk. Dr. Rossing has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis.

He is the coordinator of the EU FP7 project, PRIORITY, demonstrating that urinary proteomics can be used to stratify the prevention of renal complications in type 2 diabetes, and the Novo

Nordisk Foundation grant, PROTON, aiming at personalizing prevention of diabetic nephropathy.

He has co-authored over 420 papers, and his h-index is 69. He received the Minkowski prize in 2005, the Golgi prize in 2016 (both from the European Association for the Study of Diabetes [EASD]), and the E. Bierman award from the American Diabetes Association (ADA). Dr. Rossing has also served as president of the Danish Endocrine Society and the European Diabetic Nephropathy Study group, and as chairman of the Danish National Diabetes Registry.

Management of CKD in Diabetes

Katherine R. Tuttle

Katherine R. Tuttle, MD, FASN, FACP, FNKF
(Work Group Member)
 

Katherine R. Tuttle is the executive director for research at Providence Health Care, co-principal investigator of the Institute of Translational Health Sciences, and professor of medicine at the University of Washington, USA. Dr. Tuttle earned her medical degree and completed her residency in Internal Medicine at Northwestern University School of Medicine in Chicago, Illinois. She was a fellow in Metabolism and Endocrinology at Washington University in St. Louis, Missouri. Her Nephrology fellowship training was performed at the University of Texas Health Science Center in San Antonio, Texas.

Dr. Tuttle’s major research interests are in clinical and translational science for diabetes and CKD. She has published over 200 original research contributions and served two terms as Associate Editor for the Clinical Journal of the American Society of Nephrology and the American Journal of Kidney Disease. Dr. Tuttle has received many honors and awards, including the Medal of Excellence from the American Association of Kidney Patients, Garabed Eknoyan Award from the NKF, the YWCA Woman of Achievement Award in Science, and two Outstanding Clinical Faculty Awards at the University of Washington. Dr. Tuttle served on the Board of Directors for the Kidney Health Initiative and has chaired numerous kidney and diabetes-related working groups and committees for organizations including the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/NIH, the NKF, the American Society of Nephrology, the ISN, and the ADA.

Join the KDIGO Webinar

Register Now
Tuesday, 02 June 2020 08:00

Honoring the Past, Welcoming the Future

Honoring the Past, Welcoming the Future:
Experience the ISN Timeline

As part of the ISN’s 60th year celebrations, I am pleased to share with you a short video highlighting some of the Society’s recent achievements. These have been made possible by the passion and commitment of ISN members, steady supporters, and visionary leaders.

A unique role in global nephrology:
The International Society of Nephrology 2011-2020 

ISN Past-President John Feehally traces the evolution of the ISN's vision for meeting the challenges of the 21st century in his narration of history of the Society in “A unique role in global nephrology: The International Society of Nephrology 2011-2020”, published in the Kidney International.

The ISN continues to fulfil its role in addressing the most pressing global challenges in delivery of kidney care through its capacity building programs, continued education of all kidney health professionals, supporting research, advocating for optimal kidney health through initiatives such as 0by25, and partnering with other organizations including the WHO.

The Kenya Renal Association (KRA) and the Guatemalan Association of Nephrology (AGN) have joined the ISN as Collective Societies further strengthening a mutual commitment to the advancement of kidney care.

Collective Society status increases global activity and visibility through ISN endorsement, priority consideration for managing joint events, and complimentary participation in the Global Village at the World Congress of Nephrology (WCN).

In addition, for a tailored fee, individual members of these societies enjoy full membership benefits including Kidney International journals, special event rates, and education at the ISN Academy.

ISN looks forward to working closely with KRA and AGN to advance kidney health worldwide – together.

If you would like more information about the benefits of collective membership, please send an email to membership@theisn.org.

On May 18, 2020, the ISN represented the global kidney health community at the 73rd session of the WHO’s World Health Assembly (WHA) in Geneva.

At this historic WHA, which took place virtually due to COVID-19-related restrictions, delegates adopted a landmark resolution to press for solidarity in addressing the pandemic.

The resolution calls for a joint and intensified effort to control the spread of the virus and to ensure access to COVID-19 treatments and future vaccines.

Working alongside the NCD Alliance and larger advocacy network, the ISN contributed to the WHA 73 discussions and achieved the important goal of including the NCD’s perspective within the resolution by issuing a joint statement, as well as the official ISN statement.

The ISN holds a long-standing relationship with the WHO and reiterates the need for a global health agency. The WHA provides an excellent platform for all stakeholders, including civil society organizations such as the ISN, to deliver statements and advocate for an inclusive approach to health, especially during pandemics such as the current COVID-19 crisis.

ISN Statement
https://www.dropbox.com/s/bc9384rb63x3glj/WHA73%20Statement_revised%20by%20AWG_VJ.pdf?dl=0

Global Coalition for Circulatory Health Statement
https://www.dropbox.com/s/cafkg5gil3yrjwy/WHA73%20WHF%20GCCH%20Statement%2015052020.pdf?dl=0

Friday, 29 May 2020 12:32

KDIGO Report to be published in Kidney International and Kidney International Reports

KDIGO’s Nomenclature for Kidney Function and Disease Conference Report and Glossary will be released in the June issue of Kidney International. An executive summary and glossary will be published in KI Reports.

The KDIGO consensus conference took place in June 2019 providing a platform to discuss standardizing and refining kidney-related terminology to be more patient-centered and precise and to align communication in clinical practice, research, and public health.

Friday, 29 May 2020 12:26

WCN’21 Abstract Submission Is Open

Stand out in your field – submit an abstract for WCN’21

Submission deadline: November 18, 2020 Find out more and submit your abstract here.

Nominate a Candidate for the ISN 2021 Awards

Do you know someone who has made an outstanding contribution to nephrology? Nominate them for an ISN Award before August 27, 2020:

Send your nominations, supporting materials, and questions to the ISN Awards Coordinator.

Read about the 2019 ISN Award winners here.

In 2017, the ISN and the Australian and New Zealand Society of Nephrology (ANZSN) signed a memorandum of Understanding (MOU) to develop a partnership to advance kidney care in the Asia Pacific region.

Since then, the ISN and ANZSN have successfully co-funded ISN Programs, including Sister Renal Centers, Clinical Research, and Educational Ambassadors Program, as well as Fellowships and CME meetings.

The ISN-ANZSN collaboration within the SRC program achieved notable success in Fiji. A paper produced by the emerging hospital in the program, demonstrating that Fiji has one of the highest rates of end-stage kidney disease worldwide, was pivotal in obtaining government funding to set up a National Kidney Research and Treatment Centre to improve access to kidney care in the region.

In 2018, an ISN CME meeting was held in collaboration with the ANZSN and the APSN in Samoa highlighting the importance of early detection of AKI and screening for and managing patients with CKD in a region where kidney disease is a growing burden.

In 2019, the ISN World Congress of Nephrology was co-hosted by the ANZSN and the APSN. The ANZSN provided substantial support toward travel grants for delegates from low and middle-income countries to attend the event.

In 2020, the ISN endorsed the ANZSN 2020 Home Dialysis Conference, which brought together health care professionals, carers, and patients from Australia, New Zealand, and the Pacific to focus on building and developing home-based dialysis therapies.

ISN President, Vivek Jha, states: “This partnership reinforces the ongoing cooperation between the two societies to support the growth of nephrology in the Asia Pacific region. The successful organization of WCN19, which drew the attention of the global nephrology community to kidney health issues in the region, is an example.”

Thursday, 28 May 2020 10:50

ISN Welcomes New Chairs for the:

 Kidney Health Professionals Working Group

|

Sister Renal Centers Committee

|

ISN Advancing Clinical Trials (ACT) Committee

KIDNEY HEALTH PROFESSIONALS WORKING GROUP

Outgoing Chair

Paul Bennett
(Australia)
2018-2020

“Nephrology nurses and allied health professionals are the largest professional nephrology group, and the development of the ISN Kidney Health Professionals Working Group has been an important ISN initiative recognizing this group’s vital role. It has been an honor to serve as the working group’s Chair from 2018 to 2020. The commitment of the working group’s members in these foundation years has produced a momentum that will no doubt be enhanced under the leadership of Michele Trask.”

Incoming Chair

Michele-Anne Trask
(Canada)
2020-2022

“I am excited for the future of the Kidney Health Professionals Working Group. We have an amazing team and I know we are going to make incredible things happen. It is truly an honor to have been elected Chair of this group.”

SISTER RENAL CENTERS COMMITTEE

David Harris, Chair of ISN Programs, offers thanks to Peter Kerr and welcomes Marcelo Orias: 

 

 

“On behalf of the ISN and the ISN Programs Committee, I would like to thank Peter Kerr for his outstanding leadership of, and commitment to, the Sister Renal Center Program over the last three years. With Peter at the helm, the SRC program has gone from strength to strength. We are very grateful for the generous personal time commitment he has made to ensure the success of the SRC program.”
Outgoing Chair
Peter Kerr
(Australia)
2017-2020
“Marcelo Orias will be replacing Peter as Committee Chair, with Chih-Wei Yang, as Deputy Chair. Together with the SRC Committee Members, they will guide implementation and provide advice related to the SRC Program, which is a key component of the overall capacity building effort of the ISN and strives to bring essential teaching and training to doctors and healthcare practitioners in low resource countries. We congratulate them on their appointment and look forward to working with them.”
Incoming Chair
Marcelo Orias
(Argentina)
2020-2022

ISN RESEARCH WORKING GROUP

Adeera Levin, Chair of the ISN Research Working Group, offers thanks to Vlado Perkovic, outgoing Chair of the ISN-ACT Committee and Louise Moist, Outgoing Chair of the ISN-H4KH Initiative, and welcomes Thomas Hiemstra as Incoming Chair of the ISN-ACT Committee:

 

“ISN and the Research Working Group extend heartfelt thanks to Vlado Perkovic. His renowned expertise in clinical trials and leadership role have been critical over the last five years in the setting-up and development of the Committee aimed at facilitating high-quality clinical trials and studies in nephrology. During his leadership, great initiatives such as the Global Focus List and the ISN-ACT Toolkit have emerged. He has made an outstanding contribution in his support of the ISN.”
Outgoing Chair
Vlado Perkovic
(Australia)
2015-2020
“I welcome Thomas Hiemstra as the new Chair of the ISN-ACT Committee, taking over from Vlado Perkovic. Thomas Hiemstra was the Deputy Chair of the ISN-ACT Committee. Based at the University of Cambridge in the United Kingdom, Thomas has co-led the development of the ISN-ACT Toolkit. A clinical trialist, with expertise in trial design, conduct, analysis, and reporting, he co-leads the UK Renal Trials Network (UKRTN). Alongside the ISN-ACT Committee members, he will continue to improve global nephrology community participation in clinical trial research through a series of activities and initiatives.”
Incoming Chair
Thomas Hiemstra
(United Kingdom)
2020-2022

“The ISN thanks Louise Moist as the outgoing chair of the ISN-H4KH (Hydration for Kidney Health) Initiative. Her leadership has been essential in implementing this initiative aimed at stimulating the interest of established and new researchers to explore the role of hydration in kidney health. With the support of the ISN-H4KH Committee members and her precious guidance, all selected ISN-H4KH grant awardees successfully carried out their projects. Her commitment and energy have been greatly appreciated.”
Outgoing Chair
Louise Moist
(Canada)
ISN-H4KH initiative Chair
2015-2020

The ISN Global Kidney Care Podcast (GKCP) , to be launched this month, will initially focus on the COVID-19 pandemic.

Over time, the GKCP will provide content on science, research, and clinical aspects of nephrology, including:

  • Case-Based Discussions
  • Paradox Nephrology
  • Everyday Nephrologists
  • Latest Kidney International and Kidney International Reports Papers

The GKCP will be available via numerous podcast platforms and apps, including Apple, Stitcher, Spotify, and Google Podcast. All episodes will be free and open access.

Listen to ISN Podcast

Page 1 of 25

Global Operations Center

Avenue des Arts 1-2
1210 Brussels, Belgium
Tel: +32 2 808 04 20
Fax: +32 2 808 4454
Email contact

               

Americas Operations Center

340 North Avenue 3rd Floor
Cranford, NJ 07016-2496, United States
Tel: +1 567 248 9703
Fax: +1 908 272 7101
Email contact